Full View

Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies

GM Matthews, P Mehdipour, LA Cluse… - Blood, The Journal …, 2015 - ashpublications.org
Histone deacetylase (HDAC) inhibitors (HDACis) have demonstrated activity in
hematological and solid malignancies. Vorinostat, romidepsin, belinostat, and panobinostat …
被引用次数：58 相关文章
[PDF] researchgate.net

[PDF][PDF] Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies

GM Matthews, P Mehdipour, LA Cluse, KJ Falkenberg… - 2015 - researchgate.net
Histone deacetylase inhibitors have demonstrated activity in hematological and solid
malignancies. Vorinostat, romidepsin, belinostat and panobinostat are FDA-approved for …
[HTML] nih.gov

[HTML][HTML] Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies

GM Matthews, P Mehdipour, LA Cluse, KJ Falkenberg… - Blood, 2015 - ncbi.nlm.nih.gov
Histone deacetylase (HDAC) inhibitors (HDACis) have demonstrated activity in
hematological and solid malignancies. Vorinostat, romidepsin, belinostat, and panobinostat …

Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies

GM Matthews, P Mehdipour, LA Cluse, KJ Falkenberg… - Blood, 2015 - repository.cshl.edu
Histone deacetylase inhibitors have demonstrated activity in hematological and solid
malignancies. Vorinostat, romidepsin, belinostat and panobinostat are FDA-approved for …

Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies

GM Matthews, P Mehdipour, LA Cluse… - …, 2015 - pubmed.ncbi.nlm.nih.gov
Histone deacetylase (HDAC) inhibitors (HDACis) have demonstrated activity in
hematological and solid malignancies. Vorinostat, romidepsin, belinostat, and panobinostat …
[HTML] sciencedirect.com

[HTML][HTML] Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies

GM Matthews, P Mehdipour, LA Cluse, KJ Falkenberg… - Blood, 2015 - Elsevier
Histone deacetylase (HDAC) inhibitors (HDACis) have demonstrated activity in
hematological and solid malignancies. Vorinostat, romidepsin, belinostat, and panobinostat …

Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies

GM Matthews, P Mehdipour, LA Cluse, KJ Falkenberg… - Blood, 2015 - cir.nii.ac.jp
抄録< jats: title> Key Points</jats: title>< jats: p> Genetic studies suggest HDAC3-selective
suppression may prove useful for treatment of hematological tumors but will not induce …

Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies.

GM Matthews, P Mehdipour, LA Cluse, KJ Falkenberg… - Blood, 2015 - europepmc.org
Histone deacetylase (HDAC) inhibitors (HDACis) have demonstrated activity in
hematological and solid malignancies. Vorinostat, romidepsin, belinostat, and panobinostat …

Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies.

GM Matthews, P Mehdipour, LA Cluse, KJ Falkenberg… - Blood, 2015 - europepmc.org
Histone deacetylase (HDAC) inhibitors (HDACis) have demonstrated activity in
hematological and solid malignancies. Vorinostat, romidepsin, belinostat, and panobinostat …

Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies

GM Matthews, P Mehdipour, LA Cluse, KJ Falkenberg… - Blood, 2015 - repository.cshl.edu
Histone deacetylase inhibitors have demonstrated activity in hematological and solid
malignancies. Vorinostat, romidepsin, belinostat and panobinostat are FDA-approved for …